

![]() |
Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome |
|
Authors | ||
Published in | Clinical Oncology. 2014, vol. 26, no. 6, p. 316-22 | |
Abstract | To evaluate the tolerance and preliminary outcome of prostate cancer patients at high risk of lymph node involvement treated with normofractionated whole pelvic radiotherapy (WPRT) followed by a hypofractionated boost to the prostate with an intensity-modulated radiotherapy (IMRT) technique. | |
Identifiers | PMID: 24667210 | |
Full text | ||
Structures | ||
Research group | Groupe Miralbell Raymond (radio-oncologie) (685) | |
Citation (ISO format) | ZILLI, Thomas et al. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome. In: Clinical Oncology, 2014, vol. 26, n° 6, p. 316-22. https://archive-ouverte.unige.ch/unige:44334 |